Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Using single-cell multi-omics screening of human fetal pancreas to identify novel players in human beta cell development. | Diabet Med | 2022 | 36302085 | PubTator, text mining | PubMed |
| How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care. | Medicina (Kaunas) | 2022 | 36295546 | PubTator, text mining | PubMed |
| The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms. | Int J Mol Sci | 2022 | 36293054 | PubTator, text mining | PubMed |
| New Insight on 2D In Vitro Angiogenesis Models: All That Stretches Is Not a Tube. | Cells | 2022 | 36291145 | PubTator, text mining | PubMed |
| Hoxa9/meis1-transgenic zebrafish develops acute myeloid leukaemia-like disease with rapid onset and high penetrance. | Open Biol | 2022 | 36285442 | PubTator, text mining | PubMed |
| A performance evaluation study: Variant annotation tools - the enigma of clinical next generation sequencing (NGS) based genetic testing. | J Pathol Inform | 2022 | 36268089 | PubTator, text mining | PubMed |
| Role of microRNAs in trophoblast invasion and spiral artery remodeling: Implications for preeclampsia. | Front Cell Dev Biol | 2022 | 36263015 | PubTator, text mining | PubMed |
| Evaluation of cell-cell interaction methods by integrating single-cell RNA sequencing data with spatial information. | Genome Biol | 2022 | 36253792 | PubTator, text mining | PubMed |
| Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke. | Nat Commun | 2022 | 36253349 | PubTator, text mining | PubMed |
| Study on the mechanism of scutellarin's protective effect against ZEA-induced mouse ovarian granulosa cells injury. | Food Chem Toxicol | 2022 | 36252740 | PubTator, text mining | PubMed |
| A matter of origin - identification of SEMA3A, BGLAP, SPP1 and PHEX as distinctive molecular features between bone site-specific human osteoblasts on transcription level. | Front Bioeng Biotechnol | 2022 | 36246375 | PubTator, text mining | PubMed |
| Emerging role of circRNAs in cancer under hypoxia. | Oncol Lett | 2022 | 36238836 | PubTator, text mining | PubMed |
| Transcriptional and Epigenomic Markers of the Arterial-Venous and Micro/Macro-Vascular Endothelial Heterogeneity within the Umbilical-Placental Bed. | Int J Mol Sci | 2022 | 36233172 | PubTator, text mining | PubMed |
| Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells. | Cells | 2022 | 36230902 | PubTator, text mining | PubMed |
| Molecular targeted therapy for anticancer treatment. | Exp Mol Med | 2022 | 36224343 | PubTator, text mining | PubMed |
| Genome-wide association study for Chagas Cardiomyopathy identify a new risk locus on chromosome 18 associated with an immune-related protein and transcriptional signature. | PLoS Negl Trop Dis | 2022 | 36215317 | PubTator, text mining | PubMed |
| EphA1 receptor tyrosine kinase is localized to the nucleus in rhabdomyosarcoma from multiple species. | Biol Open | 2022 | 36214254 | PubTator, text mining | PubMed |
| Pursuing Diabetic Nephropathy through Aqueous Humor Proteomics Analysis. | Oxid Med Cell Longev | 2022 | 36211816 | PubTator, text mining | PubMed |
| A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer. | Clin Genitourin Cancer | 2022 | 36210299 | PubTator, text mining | PubMed |
| A synthetic bivalent peptide ligand of EphB4 with potent agonistic activity. | Eur J Med Chem | 2022 | 36208510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=20